Abstract:Fanchun Yang, Qingying Wang, Rui Ma, Fangzhen Deng, Jie Liu Department of Obstetrics and Gynecology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China Correspondence: Jie Liu, Department of Obstetrics and Gynecology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, No. 301, Yanchang Zhong Road, Shanghai, People's Republic of China, Email Objective: Adenomyosis patients are in a hypercoagulable state, and studies have shown that carbohydrate antigen125 (CA125) may relate to the hypercoagulability and thrombosis of patients with adenomyosis, but there is still a lack of clarity regarding the changes in CA125-related coagulation indicators. This study was to explore the changes and influencing factors of CA125-related coagulation parameters in patients with adenomyosis. Methods: Retrospective observational study conducted on 200 patients with adenomyosis (AM group), 240 patients with uterine leiomyoma (LM group) and 81 patients with cervical intraepithelial neoplasia (CIN)-III (control group), of which the coagulation parameters were detected by clinical blood sample collection and statistical method analysis and informed consent was obtained. Results: The level of CA125 in the AM group was significantly higher than that in the LM group and control group. However, thrombin time (TT) shortened in the AM group when compared with the LM and control group. Activated partial thromboplastin time (APTT) in the AM group was shorter than in the control group. Multivariate logistic regression analysis found that adenomyosis was associated with CA125 level (OR=323.860, 95% CI 90.424– 1159.924, P< 0.001), APTT (OR=1.295, 95% CI 1.050– 1.598, P=0.016), TT (OR=0.642, 95% CI 0.439– 0.938, P=0.022), menorrhagia (OR=7.363, 95% CI 2.544– 21.315, P< 0.001), dysmenorrhea (OR=22.590, 95% CI 8.185– 62.347, P< 0.001). Correlation analysis revealed that APTT (r= − 0.207) and TT (r = − 0.174) were negatively correlated with the level of CA125. Conclusion: The shortening of CA125-related APTT and TT indicates that it is meaningful to detect coagulation parameters of patients with elevated CA125 levels early, dysmenorrhea and menorrhagia, and maybe further discover the hypercoagulability and prevent the occurrence of thrombus in adenomyosis. Keywords: adenomyosis, coagulation parameters, hypercoagulability, CA125, APTT, TT Adenomyosis is a diffuse or localized lesion of endometrial glands and stroma invading the myometrium, which is a common and benign disease in gynecology. 1,2 Menorrhagia and dysmenorrhea are the main symptoms of adenomyosis. However, nearly a third of patients do not suffer from any symptoms. 3,4 In recent years, there has been an observed hypercoagulable state in patients with adenomyosis, including changes in D-dimer levels, thrombin spectrum and platelet count (PLT), which may further illustrate the pathogenesis, diagnosis as well as the therapy of adenomyosis. 5,6 Previous studies have found the activation of coagulation and a potential risk of infarction and thrombosis in patients with adenomyosis. 5 Platelets, as the primary functional cells to maintain the integrity of the vascular wall and early hemostasis, can aggregate in the site of vascular injury in patients with adenomyosis, thus participating in the changes of coagulation, which is associated with abnormal uterine bleeding and hypercoagulability. 7 Apart from platelets, activated partial thromboplastin time (APTT), prothrombin time (PT), and thrombin time (TT), as vital coagulation parameters, play an important role in the human body's coagulation and fibrinolytic system. 5,8 In patients with adenomyosis, researchers found that platelets and PT increased, which was associated with anemia. 6 In addition, one study also found that APTT and TT significantly shortened in adenomyosis patients with anemia than those without anemia. And hypercoagulability in patients with adenomyosis may be related to the elevated CA125 levels and anemia. 9 Patients with adenomyosis often have elevated serum CA125, especially in patients with thrombotic events. There were reports that the level of CA125 was significantly elevated in adenomyosis patients with cerebral infarcts, disseminated intravascular coagulation (DIC) and venous thromboembolism (VTE). 10–14 And a recent study about the correlation between hemoglobin (Hb) and coagulation parameters showed that anemia was associated with the increase of PLT and PT in patients with Adenomyosis. However, researchers pointed out that some datas, such as CA125, that may affect coagulation parameters, which need further study. 6 Therefore, we speculated th -Abstract Truncated-

Hypercoagulability in women with adenomyosis who experience heavy menstrual bleeding

Anemia-Associated Platelets and Plasma Prothrombin Time Increase in Patients with Adenomyosis.

How Does the Extent of Fibrosis in Adenomyosis Lesions Contribute to Heavy Menstrual Bleeding?

Changes of Coagulation Function in Patients with Adenomyosis and Its Clinical Significance

Dysfunctional coagulation and fibrinolysis systems due to adenomyosis is a possible cause of thrombosis and menorrhagia

[Stratified Treatment and Management of Adenomyosis].

Reduced Endometrial Glycolysis Concomitant with Increased Lesional Fibrosis in Patients with Adenomyosis Who Complained of Heavy Menstrual Bleeding

Increased endometrial expression of CC-chemokine receptor-1 in women with adenomyosis.

Enhanced Expressions of Matrix Metalloproteinase (Mmp)-2 And-9 and Vascular Endothelial Growth Factors (vegf) and Increased Microvascular Density in the Endometrial Hyperplasia of Women with Anovulatory Dysfunctional Uterine Bleeding

The risk in the patients with adenomyosis after supracervical hysterectomy

Cerebral infarcts associated with adenomyosis: a rare risk factor for stroke in middle-aged women: a case series

Reduced endometrial expression of histone deacetylase 3 in women with adenomyosis who complained of heavy menstrual bleeding.

Reduced endometrial expression of histone deacetylase 3 (HDAC3) in women with adenomyosis who complained of heavy menstrual bleeding

CA125-Associated Activated Partial Thromboplastin Time and Thrombin Time Decrease in Patients with Adenomyosis

Isolated distal deep vein thrombosis associated with adenomyosis: Case report and literature review

Immunoreactivity of CD 68 , granulocyte-macrophage colony-stimulating factors receptor and vonWillebrand factor and its association with dysmenorrhea severity and the amount of menses in adenomyosis

Clinical profiles of 710 premenopausal women with adenomyosis who underwent hysterectomy

Elevated Immunoreactivity to Tissue Factor and Its Association with Dysmenorrhea Severity and the Amount of Menses in Adenomyosis.

Uterine artery embolisation in women with symptomatic adenomyosis

Adenomyosis in women undergoing hysterectomy for abnormal uterine bleeding associated with uterine leiomyomas

Adenomyosis and Abnormal Uterine Bleeding: Review of the Evidence